Clinical Trial Update: Dexmedetomidine-esketamine for Percutaneous Radiofrequency Liver Ablation [NA]

View source ↗

Summary

The clinical trial update indicates completion of a study evaluating the combination of dexmedetomidine and esketamine for sedation during percutaneous radiofre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• Esketamine (esketamine)

Snippet

Sponsor: Peking University First Hospital | Conditions: Liver Cancer, Radiofrequency Ablation | NA | Status: COMPLETED